At My Concierge MD, we provide Tirzepatide injection, a medication used to treat type 2 diabetes. It increases insulin levels in the body and decreases glucagon, which controls the amount of glucose made by the liver.
Changes in diet and exercise are often recommended in combination with this medication. Tirzepatide is a once-weekly injection that comes in six different strengths to lower the risk of side effects.
At My Concierge MD, we also offer Wegovy (Semaglutide), another once-weekly injectable prescription medication that can assist with long-term weight management by slowing stomach emptying, reducing appetite, and increasing insulin release.
Obesity is a metabolic disease that increases the risk of chronic diseases such as type 2 diabetes, hypertension, and cardiovascular disease. So, it’s important to address obesity as a public health concern and promote healthy lifestyle changes. Obesity is characterized by excessive body fat accumulation, usually resulting from a combination of genetic, behavioral, and environmental factors.
How To Get Trizepatide Injections For Weight Loss
Contact us at 310-299-8959 to schedule an in office consult or virtual consult
- Virtual Consult with MD & Nutritionist $450
- 3 Month Supply of the best compounded semaglutide injection $750 ( Special Pricing)
- Follow Ups $200
- Lose 10 – 20% of body fat safely and effectively
What is Tirzepatide?
Tirzepatide is an investigational medication developed by Eli Lilly and Company. Tirzepatide (Mounjaro) is an FDA-approved weekly injection used for type 2 diabetes to lower blood sugar. This diabetes medication works by activating the GIP and GLP-1 receptors.
In addition to controlling blood sugar, Tirzepatide has also been shown in clinical trials to be useful for weight loss, although currently, it is not an FDA-approved weight loss drug. Tirzepatide is only indicated for adults and should be used with diet and physical activities.
What does Tirzepatide do to the body?
Tirzepatide causes weight loss through multiple mechanisms. It signals to the brain that you’re full, which helps in eating less. Tirzepatide also slows down food movement through the stomach, making you feel full for extended periods.
Studies have shown that patients with type 2 diabetes treated with Tirzepatide lost an average of 5.5 kg to 11 kg in some cases. With the highest dose of tirzepatide, 15 mg, the average body weight reduction was 22.5%, resulting in a loss of 23.6 kilograms or 52.0 pounds. The result is comparable to most types of bariatric surgery.
Therefore, Tirzepatide is not only helpful in lowering blood sugar levels but also a promising option for people struggling with obesity.
What is Tirzepatide made from?
Tirzepatide is made from glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, which are used to treat type 2 diabetes mellitus as a single therapy or with other diabetes medicines. Still, it is not approved for treating type-1 diabetes mellitus and has not been studied in patients with pancreatitis. Tirzepatide is also known as Mounjaro®.
Who can take Tirzepatide for weight loss?
People with Type 2 diabetes may experience weight loss as a side effect of taking Tirzepatide. However, currently, Tirzepatide is not FDA-approved for weight loss. Some healthcare providers may prescribe it off-label for weight loss in people without diabetes. The efficacy and safety of Tirzepatide for weight loss in people with obesity are not known.
How much weight do you lose on Tirzepatide?
On tirzepatide, participants experienced weight loss ranging from 50-57% to 78-84% across the 10-mg and 15-mg dose groups. Over 72 weeks, patients treated with tirzepatide had an average weight loss of 15-20% of their starting body weight or around 52 pounds.
Compared to the weight loss drugs Wegovy and Saxenda, tirzepatide resulted in a greater reduction in body weight. While not officially approved for weight loss, studies show that participants on tirzepatide lost an average of 5.5-11 kg (12-25 lbs).
Is Tirzepatide prescription only?
Yes, tirzepatide is a prescription-only medicine for adults with type 2 diabetes and should only be used with diet and exercise. It is not approved for weight management by the FDA and cannot be used in people with type 1 diabetes or those with inflammation of the pancreas. Do not take tirzepatide or other medicines without discussing it with your doctor.
Is Tirzepatide approved by the FDA?
Yes, tirzepatide is approved by the Food and Drug Administration (FDA) as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and obesity treatment. The approval was announced on May 13, 2022.